Lexston Life Sciences Corp.'s total assets for Q3 2024 were C$655.04K, a decrease of -15.60% from the previous quarter. TSE:LEXT total liabilities were C$142.42K for the fiscal quarter, a -24.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.